Ruxolitinib therapy is associated with improved renal function in patients with primary myelofibrosis.

Ruxolitinib therapy is associated with improved renal function in patients with primary myelofibrosis. Ann Hematol. 2019 Jul; 98(7):1611-1616.

View in: PubMed